Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Patient acceptability of circulating tumour DNA testing in endometrial cancer follow-up.

European journal of cancer care - 1 Jul 2021

Relton Anna, Collins Anna, Guttery David S, Gorsia Diviya N, McDermott Hilary J, Moss Esther L

Abstract excerpt

OBJECTIVE: Circulating tumour DNA (ctDNA) is emerging as a potential option to detect disease recurrence in many cancer types, however, ensuring patient acceptability of changing clinical practice and the introduction of new technology is paramount. METHODS: Patients enrolled in a non-intervention cohort study determining the ability of ctDNA to detect recurrent endometrial cancer (EC) were invited to participate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Circulating Tumor DNA

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cohort Studies

Share to Endometrial Neoplasms

Share to Follow-Up Studies

Share to Mutation

Share to Neoplasm Recurrence, Local

Source

Open in PubMed Open full text

Identifiers

PMID: 33616269
DOI: 10.1111/ecc.13429
PMCID: PMC11475366

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Patient acceptability of circulating tumour DNA testing in endometrial cancer follow-up.PMID 33616269Read ↗

Attitudes towards risk-reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study.Semantic proximity Read ↗

“I didn’t figure you were the sort of person who would get anal cancer”. A qualitative study of women’s insights into the challenges of a rare cancer.Semantic proximity Read ↗

When genomic and standard test results diverge: implications for breast cancer patients' preference for chemotherapy.Semantic proximity Read ↗

Outpatient visits for women with postmenopausal bleeding; What do we tell our patients? A Qualitative studySemantic proximity Read ↗

Qualitative analysis of how patients decide that they want risk-reducing mastectomy, and the implications for surgeons in responding to emotionally-motivated patient requests.Semantic proximity Read ↗

ROLE OF cfDNA AND ctDNA TO IMPROVE THE RISK STRATIFICATION AND THE DISEASE FOLLOW-UP IN PATIENTS WITH ENDOMETRIAL CANCER: TOWARDS THE CLINICAL APPLICATIONSemantic proximity Read ↗

Utility of Circulating Tumor DNA for Detection and Monitoring of Endometrial Cancer Recurrence and ProgressionSemantic proximity Read ↗

Reservations About Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations-Reply.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.